This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
HealthdirectFree Australian health advice you can count on. — Description, Dosage, Side Effects | PillsCard
OTC
HealthdirectFree Australian health advice you can count on.
18MG, Tablet, extended release
INN: METHYLPHENIDATE HYDROCHLORIDE
Data updated: 2026-04-25
Available in:
🇩🇪🇬🇧🇹🇷
Form
TABLET, EXTENDED RELEASE
Dosage
18MG
Route
ORAL
Storage
—
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
JANSSEN PHARMACEUTICALS INC
ATC Code
N06BA04
Source
FDA_OB · 021121
(
ARTG
)
CONCERTA is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Treatment should be commenced by a specialist.,A diagnosis of Attention Deficit Hyperactivity Disorder (ADHD; DSM-IV) implies the presence
of hyperactive-impulsive or inattentive symptoms that caused impairment and were present
before age 7 years.,Need for comprehensive treatment programme
CONCERTA is indicated as an integral part of a total treatment program for ADHD that may
include other measures (psychological, educational and social) for patients with this
syndrome. Stimulants are not intended for use in the patient who exhibits symptoms
secondary to environmental factors and/or other primary psychiatric disorders, including
psychosis. Appropriate educational placement is essential and psychosocial intervention is
often helpful. When remedial measures alone are insufficient, the decision to prescribe
stimulant medication will depend upon the physicians assessment of the chronicity and
severity of the patients symptoms.,Long term use
The effectiveness of CONCERTA for long-term use has not been systematically evaluated in
controlled trials. Therefore the physician who elects to use CONCERTA for extended periods
should periodically re-evaluate the long-term usefulness of the drug for the individual patient.